FGP
INSM icon

Freestone Grove Partners’s Insmed INSM Stock Holding History

Freestone Grove Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$294K Buy
+2,754
New +$333K ﹤0.01% 762
2026
Q1 		– Sell
-36,200
Closed -$6.3M – 1083
2025
Q4 		$6.3M Buy
+36,200
New +$6.61M 0.05% 333
2025
Q1 		– Sell
-7,583
Closed -$524K – 687
2024
Q4 		$524K Buy
+7,583
New +$546K 0.01% 372

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Freestone Grove Partners's INSM Position: Q2 2026 in Review

Freestone Grove Partners opened a new position in Insmed (INSM) in Q2 2026: 2,754 shares worth $294K. The stake represents ﹤0.01% of the portfolio and ranks #762 among its holdings. This is a return to the name: Freestone Grove Partners previously reported a position in INSM as recently as Q4 2025.

Freestone Grove Partners first reported a position in INSM in Q4 2024 and has held it in 3 quarters since. The position peaked at $6.3M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Freestone Grove Partners held 2,754 shares of Insmed worth $294K as of Q2 2026.
  • Insmed was a new Freestone Grove Partners position in Q2 2026.
  • Insmed made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #762 holding.
  • Freestone Grove Partners first reported a position in Insmed in Q4 2024 and has held it in 3 quarters since.
  • Freestone Grove Partners's Insmed position peaked at $6.3M in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.